Eva Serup‐Hansen

656 total citations
27 papers, 416 citations indexed

About

Eva Serup‐Hansen is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Eva Serup‐Hansen has authored 27 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Eva Serup‐Hansen's work include Colorectal and Anal Carcinomas (19 papers), Colorectal Cancer Surgical Treatments (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Eva Serup‐Hansen is often cited by papers focused on Colorectal and Anal Carcinomas (19 papers), Colorectal Cancer Surgical Treatments (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Eva Serup‐Hansen collaborates with scholars based in Denmark, Norway and Sweden. Eva Serup‐Hansen's co-authors include Poul Geertsen, Estrid Høgdall, Dorte Linnemann, Hanne Havsteen, C.F. Behrens, Patrik Sibolt, C. David Sjöström, L. Calmels, Gareth J. Thomas and Duncan C. Gilbert and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Eva Serup‐Hansen

25 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Serup‐Hansen Denmark 9 277 141 116 88 85 27 416
L.E. Millender United States 6 98 0.4× 175 1.2× 94 0.8× 99 1.1× 85 1.0× 11 386
Stefan Münch Germany 12 212 0.8× 221 1.6× 100 0.9× 81 0.9× 16 0.2× 40 368
Tadashi Takenaka Japan 13 160 0.6× 126 0.9× 69 0.6× 118 1.3× 70 0.8× 37 403
Michelina Casale Italy 9 171 0.6× 154 1.1× 69 0.6× 97 1.1× 62 0.7× 21 363
Heather Warkentin Canada 12 146 0.5× 188 1.3× 90 0.8× 137 1.6× 37 0.4× 27 366
Ashley Weiner United States 10 99 0.4× 128 0.9× 112 1.0× 60 0.7× 78 0.9× 23 321
R. Innocente Italy 11 300 1.1× 171 1.2× 336 2.9× 19 0.2× 41 0.5× 42 481
Poompis Pattaranutaporn Thailand 10 115 0.4× 80 0.6× 133 1.1× 33 0.4× 47 0.6× 29 336
Gianluca Mortellaro Italy 12 91 0.3× 162 1.1× 51 0.4× 119 1.4× 16 0.2× 32 294
T. Nonoshita Japan 12 162 0.6× 238 1.7× 80 0.7× 82 0.9× 15 0.2× 26 357

Countries citing papers authored by Eva Serup‐Hansen

Since Specialization
Citations

This map shows the geographic impact of Eva Serup‐Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Serup‐Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Serup‐Hansen more than expected).

Fields of papers citing papers by Eva Serup‐Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Serup‐Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Serup‐Hansen. The network helps show where Eva Serup‐Hansen may publish in the future.

Co-authorship network of co-authors of Eva Serup‐Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Serup‐Hansen. A scholar is included among the top collaborators of Eva Serup‐Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Serup‐Hansen. Eva Serup‐Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spindler, K.-L.G., et al.. (2025). Lower urinary tract sub-structures as predictors of late urinary toxicity in concurrent chemo-radiotherapy for anal cancer. Radiotherapy and Oncology. 204. 110708–110708.
2.
Hansen, Olfred, Tine Bjørn Nielsen, Mirjana Josipović, et al.. (2025). Stereotactic Ablative Radiation Therapy of Bone Metastases in an Oligometastatic Setting: One-Year Follow-Up of the BONY-M Phase 2 Trial. International Journal of Radiation Oncology*Biology*Physics.
3.
Sibolt, Patrik, Eva Serup‐Hansen, C.E. Andersen, et al.. (2024). Artificial intelligence-generated targets and inter-observer variation in online adaptive radiotherapy of bladder cancer. Physics and Imaging in Radiation Oncology. 31. 100640–100640. 1 indexed citations
4.
Møller, Pia Krause, Mirjana Josipović, Uffe Bernchou, et al.. (2024). MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parameters. Radiotherapy and Oncology. 192. 110090–110090. 2 indexed citations
5.
Sibolt, Patrik, et al.. (2024). ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a prospective phase II trial protocol. BMC Cancer. 24(1). 374–374. 1 indexed citations
6.
Nilsson, Martin, Per Albertsson, Birgitte Mayland Havelund, et al.. (2023). Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer. Acta Oncologica. 62(8). 897–906. 8 indexed citations
7.
Behrens, C.F., L. Calmels, C. David Sjöström, et al.. (2022). Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits. Radiotherapy and Oncology. 171. 37–42. 55 indexed citations
8.
Calmels, L., Patrik Sibolt, Eva Serup‐Hansen, et al.. (2022). Evaluation of an automated template-based treatment planning system for radiotherapy of anal, rectal and prostate cancer. Technical Innovations & Patient Support in Radiation Oncology. 22. 30–36. 21 indexed citations
9.
Behrens, C.F., et al.. (2022). Online adaptive radiotherapy of anal cancer: Normal tissue sparing, target propagation methods, and first clinical experience. Radiotherapy and Oncology. 176. 92–98. 23 indexed citations
10.
Serup‐Hansen, Eva, et al.. (2022). One-Year Treatment-Related Side Effects and Quality of Life After Chemoradiotherapy in Squamous Cell Carcinoma of the Anus. International Journal of Radiation Oncology*Biology*Physics. 115(5). 1165–1177. 4 indexed citations
11.
Haas, Susanne, et al.. (2021). Management of late adverse effects after chemoradiation for anal cancer. Acta Oncologica. 60(12). 1688–1701. 4 indexed citations
12.
Andersson, Lina, C.F. Behrens, Eva Serup‐Hansen, & Patrik Sibolt. (2021). Simulated Cone-Beam Computed Tomography Based Online Adaptive Radiotherapy of Anal Cancer — Potential Dosimetric Benefit. International Journal of Radiation Oncology*Biology*Physics. 111(3). e509–e510. 1 indexed citations
13.
Kronborg, Camilla, et al.. (2020). Measurement of circulating free DNA in squamous cell carcinoma of the anus and relation to risk factors and recurrence. Radiotherapy and Oncology. 150. 211–216. 8 indexed citations
14.
Pedersen, Torben Brøchner, et al.. (2020). Outcome following local excision of T1 anal cancers—a systematic review. International Journal of Colorectal Disease. 35(9). 1663–1671. 5 indexed citations
15.
Kronborg, Camilla, et al.. (2018). Prospective evaluation of acute toxicity and patient reported outcomes in anal cancer and plan optimization. Radiotherapy and Oncology. 128(2). 375–379. 21 indexed citations
16.
Serup‐Hansen, Eva, et al.. (2018). [Work-up and treatment of anal cancer].. PubMed. 180(12). 1 indexed citations
17.
Gilbert, Duncan C., Eva Serup‐Hansen, Dorte Linnemann, et al.. (2016). Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer. British Journal of Cancer. 114(2). 134–137. 62 indexed citations
18.
19.
Serup‐Hansen, Eva, Dorte Linnemann, Estrid Høgdall, Poul Geertsen, & Hanne Havsteen. (2014). KRAS and BRAF mutations in anal carcinoma. Apmis. 123(1). 53–59. 19 indexed citations
20.
Serup‐Hansen, Eva, et al.. (2006). A phase II study using vinorelbine and continuous 5-fluorouracil in patients with advanced head and neck cancer. Acta Oncologica. 46(3). 374–377. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L.E. Millender Breakdown of academic impact, for papers by Stefan Münch Breakdown of academic impact, for papers by Tadashi Takenaka Breakdown of academic impact, for papers by Michelina Casale Breakdown of academic impact, for papers by Heather Warkentin Breakdown of academic impact, for papers by Ashley Weiner Breakdown of academic impact, for papers by R. Innocente Breakdown of academic impact, for papers by Poompis Pattaranutaporn Breakdown of academic impact, for papers by Gianluca Mortellaro Breakdown of academic impact, for papers by T. Nonoshita
Rankless by CCL
2026